Skip to main content
lexblog.com/lib/YFCRSKB0viewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "The Drug Price Negotiation Program Faces Pushback from Private and Public Industry Participants",
    "url": "https://www.lexblog.com/2023/06/21/the-drug-price-negotiation-program-faces-pushback-from-private-and-public-industry-participants/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-YFCRSKB0",
        "url": "https://www.lexblog.com/lib/YFCRSKB0/"
    },
    "datePublished": "2023-06-21T14:32:12-04:00",
    "dateModified": "2023-06-21T11:33:40-04:00",
    "author": {
        "@type": "Person",
        "name": "Audrey Mercer, Lotan Barbaresso"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Sheppard, Mullin, Richter & Hampton LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Healthcare Law Blog",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.sheppardhealthlaw.com/?p=5854",
    "sourceStability": "may-move"
}